Liquidia (NASDAQ:LQDA) CAO Sells $195,725.37 in Stock

Key Points

• Dana Boyle sold 5,101 shares of Liquidia on April 13 at an average price of $38.37 for total proceeds of $195,725.37, reducing her stake by 2.8% to 176,918 shares; the sale was executed under a pre-arranged Rule 10b5-1 plan to cover tax withholding from vesting equity awards.
• Liquidia recently reported a quarterly beat (EPS $0.15 vs. $0.08) and revenue of $92.02M (up ~3,072% YoY) but still shows negative net margin and ROE; analysts give a consensus rating of "Moderate Buy" with a $43.44 price target amid mixed individual ratings.

Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CAO Dana Boyle sold 5,101 shares of the stock in a transaction on Monday, April 13th. The stock was sold at an average price of $38.37, for a total value of $195,725.37. Following the completion of the transaction, the chief accounting officer owned 176,918 shares of the company's stock, valued at $6,788,343.66. The trade was a 2.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dana Boyle also recently made the following trade(s):

• On Monday, January 26th, Dana Boyle sold 1,580 shares of Liquidia stock. The stock was sold at an average price of $41.65, for a total transaction of $65,807.00.

Liquidia Price Performance

Shares of NASDAQ:LQDA traded down $0.14 on Tuesday, reaching $38.71. 844,813 shares of the company were exchanged, compared to its average volume of 1,775,539. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. Liquidia Corporation has a 1-year low of $11.85 and a 1-year high of $46.67. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of -46.64 and a beta of 0.45. The company has a 50-day moving average of $36.87 and a 200-day moving average of $32.92.

Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The firm had revenue of $92.02 million during the quarter, compared to analysts' expectations of $87.49 million. The business's revenue for the quarter was up 3072.4% compared to the same quarter last year. Equities analysts forecast that Liquidia Corporation will post -1.51 earnings per share for the current fiscal year.

Analysts Set New Price Targets

LQDA has been the topic of a number of research reports. Zacks Research cut Liquidia from a "strong-buy" rating to a "hold" rating in a report on Friday, February 27th. Oppenheimer lifted their price objective on Liquidia from $16.00 to $19.00 and gave the stock an "underperform" rating in a report on Thursday, March 12th. Jefferies Financial Group upped their target price on Liquidia from $45.00 to $55.00 and gave the company a "buy" rating in a report on Tuesday, January 13th. Wells Fargo & Company raised their price target on Liquidia from $44.00 to $51.00 and gave the company an "overweight" rating in a research report on Monday, March 23rd. Finally, HC Wainwright lifted their price target on Liquidia from $50.00 to $55.00 and gave the stock a "buy" rating in a research note on Friday, March 6th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $43.44.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Liquidia during the 4th quarter worth approximately $25,000. NewEdge Advisors LLC purchased a new stake in Liquidia in the 2nd quarter valued at approximately $25,000. Skandinaviska Enskilda Banken AB publ acquired a new stake in Liquidia during the 3rd quarter valued at $30,000. FNY Investment Advisers LLC acquired a new stake in Liquidia during the 3rd quarter valued at $34,000. Finally, Covestor Ltd increased its position in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after buying an additional 359 shares in the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.